AX vs AZN · P/E 11, rev $81.3M vs P/E 28, $288.38B cap
Axos Financial Inc (AX) versus AstraZeneca PLC (AZN) — a side-by-side from cached financials, not a winner call.
Axos Financial Inc (AX) is a banks - regional company listed on US.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Latest reported AX revenue for 2026-06-30 was $81.3M. Net income was $490.4M. Revenue was up 23.5% from 2025-06-30 to 2026-06-30. AX currently screens at market cap $4.94B and trailing P/E 10.6.
AZN does not have a complete income-statement cache yet.
AX currently screens at market cap $4.94B and trailing P/E 10.6. AZN currently screens at market cap $288.38B and trailing P/E 28.0.
Not investment advice. Open the AX and AZN stock pages for the full models.
Not investment advice.